找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Atlas of Clinical PET-CT in Treatment Response Evaluation in Oncology; Stefano Fanti,Gopinath Gnanasegaran,Ignasi Carrió Book 2021 Springe

[復(fù)制鏈接]
樓主: 軍械
11#
發(fā)表于 2025-3-23 10:35:03 | 只看該作者
Conventional Radiological and PET-CT Assessment of Treatment Response Evaluation in Chemotherapy Set as surrogate markers to determine the disease status and to strategically plan therapeutic management. The chapter includes the advantages and limitations of conventional imaging and PET/CT techniques in the assessment of treatment response to chemotherapy in various cancer types, including the criteria used and recommendations.
12#
發(fā)表于 2025-3-23 16:03:02 | 只看該作者
13#
發(fā)表于 2025-3-23 19:45:56 | 只看該作者
14#
發(fā)表于 2025-3-24 01:43:29 | 只看該作者
Gabriele Hooffacker,Robert Kohlick approaches appear in most recent guidelines as part of the recommendations on the appropriate use of optimal imaging in solid tumors and lymphoma. This chapter will provide a general overview of various criteria used to assess tumor response to therapy and their advantages, limitations, controversies, and challenges.
15#
發(fā)表于 2025-3-24 06:03:07 | 只看該作者
Game Theory and Multi-Agent Optimization,onventional imaging and PET/CT in the postsurgical setting of various cancer types, reviewing several guidelines and recommendations. Besides, the potential pitfalls in the image interpretation will be discussed.
16#
發(fā)表于 2025-3-24 07:58:42 | 只看該作者
17#
發(fā)表于 2025-3-24 14:20:51 | 只看該作者
18#
發(fā)表于 2025-3-24 18:09:32 | 只看該作者
19#
發(fā)表于 2025-3-24 22:39:25 | 只看該作者
Gabriele Hooffacker,Robert Kohlickware and sequence design, a vast number of functional MRI parameters are available, which are at different stages of validation. Standardisation and validation remain a challenge to implementation. The chapter will cover the advantages, limitations and pitfalls of using MRI for treatment response assessment in oncology patients.
20#
發(fā)表于 2025-3-24 23:13:44 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 12:32
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
犍为县| 泸西县| 龙口市| 和田市| 邯郸市| 乌拉特前旗| 寻甸| 芮城县| 佳木斯市| 唐河县| 吉林市| 紫阳县| 洛宁县| 静宁县| 龙口市| 清丰县| 湛江市| 雷山县| 漳平市| 新竹县| 九江县| 屯昌县| 旬邑县| 丰镇市| 泰宁县| 长寿区| 双城市| 天门市| 富蕴县| 佳木斯市| 盐津县| 张北县| 达尔| 碌曲县| 玉门市| 云南省| 青海省| 新邵县| 梓潼县| 十堰市| 汉寿县|